Clearstead Trust, LLC Novartis Ag Transaction History

Clearstead Trust, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$95.27 - $108.47 $10,860 - $12,365	114 Added 73.55%	269 $26,000
Q4 2023 Feb 06, 2024	BUY	$92.27 - $101.54 $14,301 - $15,738	155 New	155 $15,000
Q1 2023 May 10, 2023	SELL	$80.03 - $92.81 $1,200 - $1,392	-15 Reduced 0.72%	2,060 $189,000
Q4 2022 Jan 31, 2023	SELL	$75.55 - $92.52 $7,555 - $9,252	-100 Reduced 4.6%	2,075 $189,000
Q3 2022 Nov 10, 2022	BUY	$74.61 - $87.26 $7,461 - $8,726	100 Added 4.82%	2,175 $166,000
Q4 2017 Feb 14, 2018	SELL	$72.33 - $77.64 $633,972 - $680,514	-8,765 Reduced 80.86%	2,075 $174,000
Q2 2017 Aug 21, 2017	BUY	N/A	10,840	10,840 $899,000

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Clearstead Trust, LLC, based on Form 13F filings with the SEC.

Stay updated on Clearstead Trust, LLC with notifications on news.